ClawHub

Curevac

v1.0.0

CureVac is a German mRNA pioneer focusing on vaccines, cancer immunotherapy, and rare diseases, partnered with GSK for advanced clinical development.

⭐ 0· 82·1 current·1 all-time
by@hanxueyuan

Install

OpenClaw Prompt Flow

Install with OpenClaw

Best for remote or guided setup. Copy the exact prompt, then paste it into OpenClaw for hanxueyuan/curevac.

Previewing Install & Setup.
Prompt PreviewInstall & Setup
Install the skill "Curevac" (hanxueyuan/curevac) from ClawHub.
Skill page: https://clawhub.ai/hanxueyuan/curevac
Keep the work scoped to this skill only.
After install, inspect the skill metadata and help me finish setup.
Use only the metadata you can verify from ClawHub; do not invent missing requirements.
Ask before making any broader environment changes.

Command Line

CLI Commands

Use the direct CLI path if you want to install manually and keep every step visible.

OpenClaw CLI

Bare skill slug

openclaw skills install curevac

ClawHub CLI

Package manager switcher

npx clawhub@latest install curevac
Security Scan
VirusTotalVirusTotal
Benign
View report →
OpenClawOpenClaw
Benign
high confidence
✓
Purpose & Capability
Name and description match the SKILL.md content (company history, business, technical context). The skill declares no binaries, env vars, or config paths — which is appropriate for an informational company profile.
✓
Instruction Scope
SKILL.md contains only topical guidance (when to read/what to research) and static informational content. It does not instruct the agent to read local files, access credentials, call external endpoints, or exfiltrate data.
✓
Install Mechanism
No install specification and no code files are present, so nothing is written to disk or executed during install — lowest-risk model.
✓
Credentials
The skill requests no environment variables, secrets, or config paths; there is no disproportionate credential access.
✓
Persistence & Privilege
always is false and the skill is user-invocable. Model invocation is allowed (platform default), which is normal for a read-only informational skill and not concerning by itself.
Assessment
This skill appears low-risk and coherent with its stated purpose — it's a static company profile with no code, installs, or credential needs. Consider whether you trust the unknown source (no homepage provided) and whether you need up-to-date or authoritative data: verify important facts against primary sources (company filings, official press releases, peer-reviewed literature) before using the information for critical decisions. If provenance matters to you, prefer skills with a known homepage or verifiable publisher.

Like a lobster shell, security has layers — review code before you run it.

latestvk977k0dq1st4zeysm7ambjv4n985ce4h
82downloads
0stars
1versions
Updated 4d ago
v1.0.0
MIT-0
@hanxueyuan
latest
Download

CureVac — 德国 mRNA 先驱

历史时间线

  • 2000: 从德国蒂宾根大学孵化成立
  • 2001: 发现 mRNA 可以用于蛋白质治疗
  • 2006: 首次证明 mRNA 可以用于疫苗开发
  • 2014: 获 GSK 投资
  • 2020: 新冠疫苗竞赛中与 BioNTech/Moderna 竞争
  • 2021: 疫苗临床试验结果不如预期
  • 2022: 战略转型，聚焦肿瘤免疫和罕见病
  • 2023: 与 GSK 合作开发 mRNA 流感疫苗

商业模式

mRNA 疗法 + 疫苗开发。从新冠疫苗转向肿瘤免疫和罕见病治疗。与 GSK 的合作关系是核心竞争力。

护城河分析

mRNA 技术的先发优势——比 BioNTech 和 Moderna 更早开始研究。与 GSK 的战略合作加速了临床开发。在肿瘤 mRNA 免疫治疗领域的独特布局。

关键数据

  • 2020 年 IPO 融资 €1.6 亿
  • 与 GSK 的 mRNA 合作价值超 $30 亿
  • 员工约 700 人
  • 在肿瘤和罕见病领域有 10+ 个管线

有趣事实

CureVac 的创始人 Ingmar Hoerr 在 2000 年发现，如果把裸 mRNA 注射到小鼠体内，小鼠会产生免疫反应——这个发现后来成为了 mRNA 疫苗的理论基础。但他花了 20 年才让这个想法变成现实。

Comments

Loading comments...